Bank of Montreal
MDGL icon

Bank of Montreal’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bank of Montreal’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,763
Closed -$1.86M – 4156
2023
Q4 		$1.86M Buy
+7,763
New +$1.36M ﹤0.01% 1729
2023
Q1 		– Sell
-1,089
Closed -$326K – 4030
2022
Q4 		$326K Buy
+1,089
New +$107K ﹤0.01% 2860
2021
Q2 		– Sell
-261
Closed -$31K – 4422
2021
Q1 		$31K Sell
261
-1,094
-81% -$128K ﹤0.01% 3895
2020
Q4 		$157K Buy
1,355
+949
+234% +$116K ﹤0.01% 3355
2020
Q3 		$49K Sell
406
-572
-58% -$62.1K ﹤0.01% 3442
2020
Q2 		$105K Buy
978
+698
+249% +$68.6K ﹤0.01% 3069
2020
Q1 		$17K Sell
280
-981
-78% -$81.7K ﹤0.01% 3313
2019
Q4 		$115K Sell
1,261
-2,974
-70% -$288K ﹤0.01% 3428
2019
Q3 		$365K Sell
4,235
-19,094
-82% -$1.79M ﹤0.01% 2597
2019
Q2 		$2.44M Sell
23,329
-3,021
-11% -$324K ﹤0.01% 1557
2019
Q1 		$3.3M Buy
26,350
+24,553
+1,366% +$3.05M ﹤0.01% 1394
2018
Q4 		$203K Sell
1,797
-1,101
-38% -$170K ﹤0.01% 2570
2018
Q3 		$620K Buy
2,898
+57
+2% +$14.3K ﹤0.01% 2236
2018
Q2 		$794K Buy
2,841
+1,641
+137% +$288K ﹤0.01% 2118
2018
Q1 		$140K Buy
+1,200
New +$148K ﹤0.01% 2808
2016
Q2 		– Sell
-11
Closed – – 4229
2016
Q1 		$0 Hold
11
– – ﹤0.01% 4319
2015
Q4 		$0 Hold
11
– – ﹤0.01% 4333
2015
Q3 		$1K Hold
11
– – ﹤0.01% 3880
2015
Q2 		$1K Hold
11
– – ﹤0.01% 3842
2015
Q1 		$1K Hold
11
– – ﹤0.01% 3862
2014
Q4 		$1K Buy
+11
New +$1.14K ﹤0.01% 3915
2014
Q3 		– Sell
-36
Closed -$5K – 4242
2014
Q2 		$5K Buy
+36
New +$5.26K ﹤0.01% 4170
2013
Q4 		– Sell
-86
Closed -$19K – 3840
2013
Q3 		$19K Buy
+86
New +$18.3K ﹤0.01% 3238

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bank of Montreal's MDGL Position: Q1 2024 in Review

Bank of Montreal sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2024, closing a stake of 7,763 shares — an estimated $1.86M sold.

Bank of Montreal first reported a position in MDGL in Q3 2013 and held it in 23 quarters. The position peaked at $3.3M in Q1 2019. 268 funds tracked by Wall St. Rank hold MDGL as of Q1 2024.

  • Bank of Montreal reported no remaining Madrigal Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Bank of Montreal sold 7,763 Madrigal Pharmaceuticals shares in Q1 2024, an estimated $1.86M.
  • Bank of Montreal first reported a position in Madrigal Pharmaceuticals in Q3 2013 and held it in 23 quarters.
  • Bank of Montreal's Madrigal Pharmaceuticals position peaked at $3.3M in Q1 2019.
  • 268 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.